$400 Million is the total value of ECLIPSE VENTURES, LLC's 3 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ENOVIX CORPORATION | $250,913,092,000 | +52531.0% | 17,583,258 | 0.0% | 62.74% | -21.2% | ||
| OWLET INC | $126,790,877,000 | +185085.4% | 28,492,332 | 0.0% | 31.70% | +177.3% | ||
| LHDX | LUCIRA HEALTH INC | $22,218,948,000 | +41363.3% | 6,223,795 | 0.0% | 5.56% | -37.9% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-04-27
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| OWLET INC | 7 | Q2 2023 | 100.0% |
| ENOVIX CORPORATION | 6 | Q1 2023 | 91.4% |
| LUCIRA HEALTH INC | 6 | Q1 2023 | 8.9% |
| OWLET INC | 4 | Q2 2024 | 100.0% |
View ECLIPSE VENTURES, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-28 |
| 13F-HR | 2024-08-07 |
| 13F-HR | 2024-05-06 |
| 13F-HR | 2024-02-06 |
| 13F-HR | 2023-11-02 |
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-02 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-11 |
View ECLIPSE VENTURES, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.